Trial site
Ziemelkurzemes regionala slimnica SIA
Ventspils, 3601, LatviaEU-13 widening countryNot linked to an institution yet
The trials here
What the 6 trials at this site are about, from their registry records.
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Immunovant Sciences GmbH2 trials
- 4d Molecular Therapeutics Inc.1 trial
- Alvotech Swiss AG1 trial
- Amgen1 trial
- Shenzhen Oculgen Biomedical Technology Co. Ltd.1 trial
Running trials
Not yet recruiting
A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
2026-526648-11-00· Phase 2/3· Shenzhen Oculgen Biomedical Technology Co. Ltd.· Source
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
2025-524001-33-00· Phase 2· Immunovant Sciences GmbH· Source
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
NCT07614776· Phase 3· Amgen· Source
Recruiting
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema
2025-522231-34-00· Phase 3· Alvotech Swiss AG· Source
Active, not recruiting
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-2)
2025-521349-25-00· Phase 3· 4d Molecular Therapeutics Inc.· Source
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323· Phase 2· Immunovant Sciences GmbH· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error